408
Participants
Start Date
December 19, 2017
Primary Completion Date
July 19, 2022
Study Completion Date
July 19, 2022
VB-111 + Paclitaxel
VB-111 will be administered intravenously at a dose of 1x10e13 VPs every 2 months Paclitaxel will be administered intravenously at a dose of 80mg/m2 every week
Placebo + Paclitaxel
Placebo will be administered intravenously every 2 months Paclitaxel will be administered intravenously at a dose of 80mg/m2 every week
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Westchester Medical Center, Hawthorne
Northwell Health Cancer Institute, Lake Success
Women's Cancer Care Associates, LLC, Albany
Health Quest Medical Practice, Division of Gynecology/Oncology Gyno Dyson Cancer Center Vassar Brothers Medical Center, Poughkeepsie
SUNY Upstate Medical University, Syracuse
West Penn Hospital, Pittsburgh
Penn State Hershey Medical Center, Hershey
St. Luke's University Health Network, Bethlehem
The University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia
Hospital Universitario de Donostia Edificio Onkologikoa- Planta baja, Sala de Ensayos Clinicos, Donostia / San Sebastian
Massachusetts General Hospital, Boston
Holy Cross Hospital, Silver Spring
University of Maryland, Baltimore
Wake Forest Baptist Medical Center, Winston-Salem
UNC Chapel Hill, Chapel Hill
Duke University-Duke Cancer Institute, Durham
Hospital Gregorio Marañon Módulo prefabricado Oncología, Planta Baja, Madrid
MD Anderson Cancer Center Madrid Unidad de ensayos Clinicos, Madrid
Hospital Universitario Clínico San Carlos., Madrid
GHS Cancer Institute, Greenville
Emory University, Atlanta
UF Health, Gainesville
University of Miami, Miami
UAB Division of GYN Oncology, Birmingham
University of Kentucky, Lexington
Hospital Universitario Virgen del Rocío Servicio Oncología Médica. Ensayos Clínicos. Edificio CDCA, Seville
University of Cincinnati, Cincinnati
Womens Cancer Center/Kettering Cancer Care, Kettering
Instituto Valenciano de Oncología Médica (IVO, Valencia
Consorcio Hospitalario General Universitario de Valencia Servicio de Oncología Médica - Unidad de Investigación, Valencia
Indiana University School of Medicine, Indianapolis
St. Vincent Gynecologic Oncology, Indianapolis
Parkview Cancer Institute, Fort Wayne
Karmanos Cancer Institute, Detroit
Henry Ford Health Hospital, Detroit
Rabin Medical Center, Petah Tikva
Froedtert and Medical College of Wisconsin, Milwaukee
University of Wisconsin, Madison
Marshfield Clinic Cancer Care & Research Center, Marshfield
Sanford Clinical Research, Sioux Falls
Sanford Medical Center, Fargo
Midwestern Regional Medical Center, Inc, Zion
Rush University Medical Center, Chicago
Carle Cancer Center, Urbana
University of Kansas Cancer Center, Westwood
Ochsner Clinic Foundation, New Orleans
University of Oklahoma Health Sciences Center-Stephenson Cancer Center, Oklahoma City
Memorial Hermann, Houston
UT Health, San Antonio
Texas Oncology, Austin Central - USO, Austin
Arizona Oncology Associates, PC - HAL - USO, Phoenix
Arizona Oncology Associates, PC - HAL - USO, Tempe
Western Regional Medical Center, Goodyear
University of Arizona Cancer Center, Tucson
New Mexico Cancer Care Alliance, Albuquerque
UCLA-JCCC-Women's Health Clinical Research Unit, Los Angeles
Hadassah Medical Center, Jerusalem
Olive View UCLA Medical Center, Sylmar
The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange, Orange
University of California, Irvine Medical Center/Chao Family Comprehensive Cancer Center, Orange
Sansum Clinic - USO, Santa Barbara
University of California - San Francisco, San Francisco
Willamette Valley Cancer Institute and Research Center, Eugene
MultiCare Institute for Research & Innovation, Tacoma
Hartford HealthCare Cancer Institute at the Hospital of Central Ct, Hartford
Hartford Healthcare, Hartford
University of Michigan, Ann Arbor
Dartmouth- Hitchcock Medical Center, Lebanon
Atlantic Health System/Morristown Medical Center, Morristown
Rutgers New Jersey Medical School, Newark
Universtiy of Vermont, Burlington
Rambam Medical Center, Haifa
Shaare Tzedek Medical Center, Jerusalem
Chaim Sheba Medical Center, Ramat Gan
Kaplan Medical Center, Department of Oncology, Rehovot
Aichi Cancer Center, Nagoya
Kurume University Hospital, Kurume
Sapporo Medical University Hospital, Sapporo
Tohoku University Hospital, Sendai
National Cancer Center Hospital East, Kashiwa
Ehime University Hospital, Tōon
Iwate Medical University Hospital, Shiwa-gun
National Defense Medical College Hospital, Tokorozawa
National Cancer Center Hospital, Chuo-ku
Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto
Niigata Cancer Center Hospital, Niigata
Hokkaido University Hospital, Sapporo
Centrum Badan Klinicznych Jagiellonskiego Centrum Innowacji, Krakow
Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie, Olsztyn
MedPolonia Sp. z o.o., Poznan
Parc Taulí Hospital Universitari Edifici Santa Fe, Planta 0, Sala de recerca 3, Barcelona
Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona
GOG Foundation
NETWORK
Vascular Biogenics Ltd. operating as VBL Therapeutics
INDUSTRY